Without Eric Lefkofsky Tempus Wouldnt Be Where It Is Today

Tempus, A startup technology/cancer research company located in the city of Chicago makes it a mission to care for cancer patients and their loved ones before anything else. Tempus Labs can care for cancer patients and their loved ones just by simply doing their research for molecular data in order to personalize cancer treatment options but they go the extra mile by hiring enough employees so there is someone there to answer patients questions and help them find the information they are looking for whenever it arises. Tempus Labs has been around for a little over two years now and they have come further in their research than any other cancer data research company has.

Not only is Tempus good caring for their patients and their patients loved ones by being there around the clock to answer any questions that arise in their patients head but they also are good at finding ways to improve cancer research in order to help doctors who specialize in cancer treatment to rid their patients of the nasty illness in which cancer really it. Tempus makes it possible for people to continue to live their lives not only by making them happy but by keeping them healthy. Having data from previous patients can potentially stop another patient with similar demographics having to go through a treatment that might not work very well for them but instead put them on a cancer treatment plan that will work excellent for them.

Eric Lefkofsky Co-founder of Tempus and Founder of Lefkofsky Family Foundation alongside his wife Liz Lefkofsky has a goal in life to spend as much of his time as he can finding ways to enhance the lives of humans so that they can live healthier, longer, happier lives. Lefkofsky has been a big help in raising money for Tempus so they can continue to provide data research for people struggling with cancer and their loved ones involved too. Lefkofsky recently helped Tempus raise 80 million dollars towards research and in total has helped Tempus Labs raise over 200 million dollars towards cancer research of molecular data.

To Read More Click Here

Eric Lefkofsky And The Technology Of Tempus

Tempus is a company that specializes in the technology of battling cancer. It’s Co-founder, Eric Lefkofsky, has a strong desire to attack, from a scientific standpoint, the very disease that has ravaged so many people. He has a supportive team who has the same visions and goals. They have joined together in the fight to help as many cancer patients as they can through research.

Eric Lefkofsky is the head of many other companies that are extremely successful. But none have the heart of Eric Lefkofsky like this particular research organization. Eric Lefkofsky actually had a dream that sparked his strong convictions about creating a place where scientist and medical researchers would freely be able to search for cures for the various forms of cancer.

They secured a place where all types of data could be used and stored to help patients who were affected by this deadly disease. And there has been some success. The information gathered helps some patients have a better quality of life. Other patients are able to extend time with their loved ones because of the research and results discovered at Tempus. There is still a long way to go, as many new strands of cancer continuously surface. But the physicians, scientist and research teams are determined to use all of their knowledge to help find a cure for cancer in all forms. The medical community and other organizations have encouraged Eric Lefkofsky and the Tempus Technology Company with grants and funding to continue their works and research studies.

Just as new strands of the cancer disease surface, so does more people that come to support the cause of the cure for cancer. From our universities and colleges, more students are joining the cause. We are expecting even greater discoveries for the Tempus Company. And we salute Eric Lefkofsky and The Technology of Tempus that is present to provide the medical community with data that supports any cure for any strand of cancer.

To Learn More Click Here

Meet the Chief of Robotic Surgery—Dr. David Samadi

Dr. David Samadi is one of the best prostate surgeons, committed to ensuring that there is a successful treatment of prostate cancer. He has been able to help men of his ages overcome health challenges, which ensuring quality life even after prostate treatment. Dr. David Samadi has carried out over 7000 robotic surgeries, which earns him one of the best surgeons in the world. Samadi is also considered one of the leading prostate surgeons in New York, and the only one who has been able to conduct a SMART surgery using de Vinci robotic system.

Dr. David Samadi’s childhood and education

Dr. David Samadi’s interesting childhood path began in 1979 when he was 15 years. He moved to Belgium with his brother, Dan, but later moved to Northern London. Unfortunately, the family separated as a result of the Iranian Revolution, forcing David to live without his parents. Amidst the challenges, Samadi had only one dream; to become a successful doctor when he grew up. He continued with his studies in America and by 1990, he completed his degree program at Stony Brook School of Medicine where he earned an M.D. After two years, Dr. David Samadi completed his postgraduate program at Montefiore Medical Centre and immediately joined the Memorial Sloan Kettering Cancer Center for oncology fellowship. In 2002, he enrolled at Henri Hospital Creteil for robotic radical prostatectomy fellowship. This educational background resulted became his stepping stone to the current successful career.

Dr. David Samadi’s SMART technique

Dr. David Samadi’s SMART technique (Samadi Modified Advanced Robotic Technique) enhances patient experience through the promotion of sexual functionality and continence. The technique has resulted in successful surgeries with more than 95 of Dr. David Samadi’s patients being continent while 85% of them is remaining sexually active. The Dr. considers the technique one of the most cutting-edge technologies that reassure patients who feel they are well taken care of. Dr. David Samadi SMART technique transcends the challenges and limitations of conventional surgery with minimal side effects. Using this technique, Dr. Samadi believes that patients will always have a quick recovery and higher response rates.

Dr. David Samadi’s live show

In addition to his career, Dr. David Samadi hosts a Sunday program on Fox News Channel where he has worked for several years addressing issues related to prostate cancer and overall health. He also launched a health program on an am970 radio program in which he engages directly with patients and interested clients.

To know more visit @: www.roboticoncology.com/

Lifeline Screening for Bone Density Can Prevent Fractures

As the population of the United States grows increasingly older, it is important to do everything possible to minimize the risks we face. The fact is that as we age, our bodies begin to have certain health issues but there are things we can do to win the battle with aging. Partners in the battle are the Lifeline Screening Company, which provides a variety of tests that can help patients take positive steps to improve their health.

One silent disease that can affect men and women is osteoporosis. This disease which causes weakening of the bones, making them brittle and fragile, often has no symptoms. A person may not discover they suffer from osteoporosis until they experience a break or a fracture from a fall. Once one of the major bones in the body is broken, a person is set up for possible surgeries and a long rehabilitation. Here are some commonly asked questions about Lifeline Bone Density Screening.

What is involved in this test?

The Bone Density Screening uses a pulse-echo ultrasound to detect the thickness of the bone. The test is usually done on patient’s heel and is not invasive or painful.

Why is the test done on the heel?

The heel most closely resembles the larger bones in the body such as the tibia or the femur. The heel is also a weight bearing bone which is important as far as density and strength predictions.

How accurate is the Lifeline Bone Density Screening?

This test is approximately 90% accurate. Physicians use the information from the screening along with other lifestyle factors such as smoking, diet, exercise, and calcium intake to make recommendations to the patient about treatment possible remedies.

Do tests like the Lifeline Bone Density Screening have to be approved by regulating agencies?

The Lifeline Screenings have been approved by the FDA Center for Developmental and Radial Health Centers which monitors and approves this type of testing nationally.

Lifeline Bone Density Screenings are available in over 15,000 screening events and over 50 cities in the United States. Lifeline also offers other important screenings such as testing for Type 2 Diabetes, Colorectal Cancer, and Prostate Cancer. Taking advantage of these convenient and painless screenings can help prevent many serious conditions and ultimately enrich the quality of life. Discovering health issues before they affect you is a powerful and important tool as you plan your healthcare.

To Read More : www.lifelinescreeningblog.com/

A Unique Approach to Cancer Treatment at Cancer Treatment Centers of America

“Nearly one in seven men(one in five if your African American), will be diagnosed with prostrate cancer in their lifetime.”

The National Football League Alumni Association, Cancer Treatment Centers of America, and LabCorp are teaming together to form an awareness for prostrate cancer campaign. From September 1 – October 15th, men over 40 years of age who meet certain eligibility requirements will be able to qualify for a free Prostrate Specific Antigen(PSA) screening from LabCorp in any of the 1750 locations nationwide. After the initial 2000 free slots are filled, these eligible men can still get their screening for the discount rate of $25.00. However, screenings must be done within six months from initial sign-up date.

An estimated 161,360 new cases of Prostrate cancer are expected to be diagnosed in 2017. (That’s an average of 13,447 new cases per month)! Family history and race (African American) are the most common risk factors. If your PSA factor is out of normal range, it isn’t necessarily a diagnosis of cancer, it could just be alerting of certain risk factors which you should discussed with your doctor.

The Cancer Treatment Centers of America offer a unique approach to treating cancer, which is just as unique as each person is. The staff at The Cancer Treatment Centers of America are professional and specific in treating CANCER, making a commitment of their time and talent to the treatment of cancer at all stages.

There are five Cancer Treatment Centers of America hospitals in the United States. Located in Philadelphia,Pennsylvania; Tulsa, Oklahoma; near Atlanta, Georgia; Chicago, Illinois and Phoenix, Arizona. Each center delivering a personalized, “whole-person” care with the state-of-the-art technology and best treatments to each patient that comes through our doors.

The Cancer Treatment Centers of America staff of professional experts believe they are treating more than just a disease, they are treating people and families that have been affected by this disease.

To Learn More : http://www.myctca.com

Eric Lefkofsky’s Contribution to Better Cancer Care

Healthcare costs in America have gone up due to the increase of intensity and rates for those services. Due to the increase in population in America, the amount of revenue spent on healthcare has increased. In addition, the aging factor has also played a role in the increase in costs for healthcare services. The type of disease however determines the amount spent on treating the conditions.

Despite all of those costs going up, the Lefkofsky Foundation has played a big role in the easing of such costs. Founded by Eric and his wife Elizabeth, the foundation promotes the cause of researching for the cure of cancer and developing revolutionary therapies that treat patients. At Tempus, Lefkofsky has been able to help physicians come up with custom real-time treatments for cancer patients based on collected data and analyzing molecular therapies rhyming with the patient’s genetic sequence.

American born Eric Paul Lefkofsky is an industrious entrepreneur and one of the industry’s biggest technology icons. Eric co-founded Tempus and serves as CEO. He has also co-founded Groupon, Echo Global Logistics, InnerWorkings, Mediaocean, and Uptake. He is popular for his philanthropic moves with the goal of acquiring a cure for cancer.

The University of Michigan graduated co-founded an internet company known as Starbelly. The company that dealt with the sale of promotional items which led to its quick development. The venture was later sold to Halo industries in 2000. As a result of the sale, Eric joined Halo Industries and served as CEO for a year before creating InnerWorkings. The printing solutions provider experienced a successful first year and continued growing until he left in 2012.

Over the years, Lefkofsky developed an interest for the cancer medication and treatment. He was driven to develop custom cancer treatments and even develop a cure. This passion led to the creation of the Tempus, where he serves as chief executive officer.

Read More Click Here